Alvotech ALVO
NASDAQ ALVO
$5.84 -0.04 (-0.68%)
At close: Sep 22, 2026 · 4:00 PM EDT

Alvotech (ALVO) Cash from Operations (2021 - 2026)

Alvotech's (ALVO) quarterly Cash from Operations came in at -$19.8 million in Q2 2026, down 135.49% on a YoY basis from $55.7 million in Q2 2025, and up 67.26% quarter-over-quarter from -$60.4 million in Q1 2026.

Analysis

Alvotech (ALVO) Cash from Operations (2021 - 2026) Analysis & Trends

Alvotech (ALVO) has reported Cash from Operations for 6 consecutive years, with -$19.8 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Cash from Operations fell 135.49% year-over-year to -$19.8 million; the trailing twelve-month figure through Jun 2026 stood at -$198.7 million (up 17.27% YoY), and the FY2025 full-year result was -$50.2 million, up 78.81% from the prior year.
  • Cash from Operations improved to -$19.8 million in Q2 2026 per ALVO's latest filing, from -$60.4 million in the prior quarter.
  • Across five years, Cash from Operations topped out at $147.4 million in Q4 2025 and bottomed at -$312.4 million in Q4 2022.
  • Historically, Cash from Operations has averaged -$95.4 million across 5 years, with a median of -$66.0 million in 2024.
  • The sharpest annual moves came in 2025 and 2026: Cash from Operations jumped 210.17% in 2025, then slumped 581.54% in 2026.
  • Over 5 years, Cash from Operations stood at -$312.4 million in 2022, then climbed by 0.07% to -$312.2 million in 2023, then climbed by 24.13% to -$236.8 million in 2024, then jumped by 162.25% to $147.4 million in 2025, then tumbled by 113.42% to -$19.8 million in 2026.
  • According to Business Quant data, Cash from Operations over the past three periods registered -$19.8 million, -$60.4 million, and $147.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. (Qtr)
1 Teva Pharmaceutical Industries 46.72 Bn 43.07 Bn 2.15 Bn 411.00 Mn
2 Viatris 19.64 Bn 18.75 Bn 1.46 Bn 381.80 Mn
3 Dr Reddys Laboratories 10.36 Bn 10.22 Bn 396.53 Mn -9.79 Mn
4 Amneal Pharmaceuticals 6.44 Bn 6.39 Bn 334.51 Mn -21.24 Mn
5 Bausch Health Companies 2.11 Bn 1.24 Bn 2.10 Bn 670.00 Mn
6 Ani Pharmaceuticals 1.88 Bn 1.52 Bn 165.89 Mn 56.67 Mn
7 Alvotech 1.83 Bn 1.69 Bn 2.56 Mn -19.79 Mn
8 Amphastar Pharmaceuticals 1.04 Bn 751.07 Mn 93.47 Mn 51.32 Mn
9 Fennec Pharmaceuticals 382.22 Mn 340.97 Mn 17.15 Mn -
10 NutriBand 94.45 Mn 91.03 Mn 181,874.00 -584,999.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -19.79 Mn
Mar 31, 2026 -60.43 Mn
Dec 31, 2025 147.44 Mn
Sep 30, 2025 -265.93 Mn
Jun 30, 2025 55.74 Mn
Mar 31, 2025 12.55 Mn
Dec 31, 2024 -236.84 Mn
Sep 30, 2024 -71.64 Mn
Jun 30, 2024 -50.60 Mn
Mar 31, 2024 -75.40 Mn
Dec 31, 2023 -312.19 Mn
Jun 30, 2023 -41.87 Mn
Dec 31, 2022 -312.39 Mn
Jun 30, 2022 -103.57 Mn
Dec 31, 2021 -70.76 Mn
Sep 30, 2021 -72.68 Mn
API Access

Alvotech Cash from Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-operations&ticker=ALVO&period=max&api_key=YOUR_API_KEY